Growth suppression of renal cell carcinoma cell lines by a dominant negative H-ras mutant
Growth suppression of renal cell carcinoma cell lines by a dominant negative H-ras mutant
批准号:
08671786
负责人:
SHINOHARA Nobuo
金额:
$1.34万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1997
中文摘要
为了检测显性阴性H-ras突变体N116Y的高表达对肿瘤细胞增殖的影响,构建了高效的N116Y表达载体pZIP-N116Y,并通过脂质体转染法将N116Y导入肾癌细胞株ACHN、NT-2、SMKT-R3。_pZIP-N116Y可完全抑制ACHN、NT-2、SMKT-R3的集落形成,G418筛选后无细胞存活。虽然_pZIP-N116Y可能是肾癌细胞的有效抑制因子,但它的抑制活性可能依赖于neo基因的失活。为了排除这种可能性,我们检测了6株同时含有_pZIP-N116Y和_pSV2_<;neo>;的肾癌细胞系(ACHN、NT-2、OSRC2、SMKTR-2、SMKTR-3、SMKTR-4)的集落形成能力。G418抗性克隆数分别为4%(ACHN)、6%(NT-2)、10%(OSRC2)、13%(SMKTR-2)、20%(SMKTR3)和9%(SMKTR4)。为了阐明N116Y抑制肾癌细胞生长的机制,我们分析了介导RAS蛋白活化的SOS蛋白的表达。AII5肾癌细胞株(ACHN、NT-2、SMKT-R-3、SMKT-R-4、OS-RC-2)分别高表达SOS蛋白,而正常肾组织中SOS蛋白含量很低,提示显性阴性H-ras突变体N116Y可抑制肾癌细胞的增殖。
英文摘要
We examined whether N116Y,which derived from the v-H-ras oncogene by substituting the asparagine-116 with tyrosine, can inhibit the growth of renal cell carcinoma (RCC) cell lines.In order to examine whether high expression of a dominant negative H-ras mutant, N116Y,affects tumor cell proliferation, we constructed an efficient N116Y expression vector, _pZIP-N116Y,and transfected three RCC cell lines (ACHN,NT-2, SMKT-R3) by the lipofection procedure. Transfection of _pZIP-N116Y completely inhibited the colony formation of ACHN,NT-2, SMKT-R3 and no cell survived after G418 selection. Although _pZIP-N116Y may be a potent suppressor of RCC cells, it is possible that the suppressor activity of _pZIP-N116Y depends on neo gene inactivation. To exclude this possibility, we examined the colony forming ability of 6 RCC cell lines (ACHN,NT-2, OSRC2, SMKTR-2, SMKTR-3, SMKTR-4) containing both _pZIP-N116Y and _pSV2_<neo> by cotransfection of these plasmids at the rates of 10 : 1 and 0 : 1. The numbers of G418-resistant colonies were 4% (ACHN), 6% (NT-2) , 10% (OSRC2) , 13%(SMKTR-2) , 20% (SMKTR-3) , and 9% (SMKTR-4) in comparison with the control transfection (0 : 1).To clarify the mechanism of growth suppression in RCC cell lines by N116Y,we analyzed the expression of son of sevenless (Sos) protein which mediates the the activation of Ras protein . AII5 RCC cell lines (ACHN,NT-2, SMKT-R-3, SMKT-R-4, OS-RC-2) expressed compartively high levels of Sos protein, while the amount of Sos protein was very small in normal kidney tissues.These results suggest that a dominant negative H-ras mutant, N116Y,can suppress the proliferation of RCC cell lines.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Shinohara, N.et al.: "Growth suppression of renal cell carcinoma cell lines by a dominant negative H-ras mutant." Journal of Urology. 155(5). 407A (1996)
Shinohara, N.等人:“显性失活 H-ras 突变体对肾细胞癌细胞系的生长抑制。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shinohara,N.et.al.: "Growth suppression of renal cell carcinoma cell lines by a dominant negative H-ras mutant." Journal of Urology. 155(5). 407A- (1996)
Shinohara,N.et.al.:“显性失活 H-ras 突变体对肾细胞癌细胞系的生长抑制。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shinohara, N.et al: "The significance of ras guanine nucleotide exchange factor, son of sevenless protein, in renal cell carcinoma cell lines." Journal of Urology. 158(3). 908-911 (1997)
Shinohara, N. 等人:“七少蛋白之子 ras 鸟嘌呤核苷酸交换因子在肾细胞癌细胞系中的意义。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shinohara,N.et.al.: "The significance of ras guanine nucleotide exchange factor,son of sevenless protein,in renal cell carcinoma cell lines." Journal of Urology. 158(3). 908-911 (1997)
Shinohara, N.et.al.:“七少蛋白之子 ras 鸟嘌呤核苷酸交换因子在肾细胞癌细胞系中的意义。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Shinohara, N.et al.: "The significance of ras guanine nucleotide exchange factor,son of sevenless protein,in renal cell carcinoma cell lines." Journal of Urology. 158(3). 908-911 (1997)
Shinohara, N. 等人:“七少蛋白之子 ras 鸟嘌呤核苷酸交换因子在肾细胞癌细胞系中的意义。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 7 条
Discovery of diagonositc and therapeutic biomarker by circulating tumor endothelial cells in metastatic renal cell carcinoma
-
批准号:23592320
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.16万
-
财政年份:2011
-
负责人:SHINOHARA Nobuo
-
依托单位:
Development of new screening system for anti-angiogenic drugs using tumor associated endothelial cells derived from renal cell carcinoma
-
批准号:20591847
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2008
-
负责人:SHINOHARA Nobuo
-
依托单位:
Analysis of expression pattern of the gene which is related to the radiation sensitivity in urothelial cancer and its clinical application
-
批准号:15390482
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$5.12万
-
财政年份:2003
-
负责人:SHINOHARA Nobuo
-
依托单位:
Establishment of gene therapy against bladder cancer utilizing gelsolin gene and a dominant negative ras mutant
-
批准号:12470326
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$4.03万
-
财政年份:2000
-
负责人:SHINOHARA Nobuo
-
依托单位:
Preclinical study for gene therapy against bladder cancer utilizing gelsolin gene and a dominant negative ras mutant
-
批准号:10470327
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$3.46万
-
财政年份:1998
-
负责人:SHINOHARA Nobuo
-
依托单位:
海外基金